NCT02286778View on ClinicalTrials.gov

Eradication of Malignant Carcinoma in the Breast Tissue

PHASE2/PHASE3CompletedINTERVENTIONAL
Enrollment

60

Participants

Timeline

Start Date

February 29, 2016

Primary Completion Date

January 31, 2017

Study Completion Date

August 1, 2017

Conditions
Breast Cancer
Interventions
DIETARY_SUPPLEMENT

Acetogenins

Acetogenins BID for 12 months

DIETARY_SUPPLEMENT

Placebo

All Listed Sponsors
lead

Optimal Health Research

OTHER

NCT02286778 - Eradication of Malignant Carcinoma in the Breast Tissue | Biotech Hunter | Biotech Hunter